Evidence map›Paper›PMID 36363571›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Sevoflurane Does Not Promote the Colony-Forming Ability of Human Mesenchymal Glioblastoma Stem Cells In Vitro.

Tomohiro Shoji, Mikio Hayashi, Chisato Sumi, Munenori Kusunoki, Takeo Uba, Yoshiyuki Matsuo, Kiichi Hirota

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tomohiro ShojiDepartment of Emergency Medicine, Kyoto Katsura Hospital, Kyoto 615-8256, Japan.ORCID 0000-0002-4185-2010
Mikio HayashiDepartment of Physiology, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.ORCID 0000-0002-9670-5683
Chisato SumiDepartment of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.
Munenori KusunokiDepartment of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.
Takeo UbaDepartment of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.
Yoshiyuki MatsuoDepartment of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.ORCID 0000-0002-3183-4871
Kiichi HirotaDepartment of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.ORCID 0000-0003-1110-0827
Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsGlioblastomaApoptosisCell Line, TumorCell ProliferationHumansNeoplastic Stem CellsSevofluraneSevofluraneglioblastoma stem cellssevofluranestemness

Identifiers

PMID36363571
PMCPMC9694357
OpenAlexW4308514776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.